Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
  • Germany
  • Austria
  • Switzerland
  • Sweden
  • United Kingdom
  • Belgium
  • Denmark
  • Netherlands
  • USA
  • Canada
  • Finland
  • Estonia
  • Latvia
  • Lithuania
  • Luxembourg
  • Spain
  • Czech Republic
  • France
  • Hungary
  • Iceland
  • New Zealand
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
  • Fintech
  • AI
  • Health Tech
  • Data Science
About
Atlas Venture specializes in investing in early-stage life sciences innovation by partnering with entrepreneurs to create breakthrough biotechnology companies.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Atlas Venture focuses on creating and building breakthrough biotechnology companies. They partner with life science entrepreneurs to translate innovation into novel medicines, emphasizing a collaborative, sciencefirst, patientcentric culture.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on early-stage investments across technology and healthcare sectors. With deep experience in the North American market, successfully closed over 50 deals with a notable number of exits. Specializes in growth equity, employing a hands-on approach to drive operational improvements. Recognized for a robust track record in fostering innovation and delivering exceptional returns.

Atlas Venture Contacts Information

Primary contact

Secondary contact

Team

Tandee Newman

Steven Robinette

Sarah Coughlin

Sarah Gerrish

Sarah Coughlin

Rajesh Devraj

Philip Austin

Peter Barrett

Ommer Chohan

Michael Gladstone

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp